9,10-dimethyl-1,2-benzanthracene has been researched along with prostaglandin d2 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boscá, L; Cano, A; Millán, O; Peinado, H; Pérez-Sala, D; Rico, D; Rojas, JM; Stamatakis, K; Zarich, N | 1 |
1 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and prostaglandin d2
Article | Year |
---|---|
Potentiation of tumor formation by topical administration of 15-deoxy-delta12,14-prostaglandin J2 in a model of skin carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Administration, Topical; Animals; Apoptosis; Carcinogens; Cell Transformation, Neoplastic; Cyclooxygenase 2; Disease Progression; Drug Interactions; Female; Immunologic Factors; Keratinocytes; Mice; Papilloma; Prostaglandin D2; Skin Neoplasms | 2006 |